SCHEMBL10102252

SCHEMBL10102252

Cc1cc2c(cc1O)C(=O)CCC2

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAOA P21397 4/20 0.53
MAOB P27338 4/20 0.53
PRKCI P41743 1/20 0.53
MAPK1 P28482 2/20 0.49
NPSR1 Q6W5P4 2/20 0.49
MEN1 O00255 2/20 0.49
KMT2A Q03164 2/20 0.49
HSD17B1 P14061 5/20 0.47
BAZ2B Q9UIF8 1/20 0.44
ALDH1A1 P00352 3/20 0.43
MAPT P10636 3/20 0.43
KDM4E B2RXH2 2/20 0.43
HPGD P15428 2/20 0.43
CYP1A2 P05177 1/20 0.43
CYP3A4 P08684 1/20 0.43
CYP2D6 P10635 1/20 0.43
G6PD P11413 1/20 0.43
CYP2C9 P11712 1/20 0.43
PKM P14618 1/20 0.43
ALOX15 P16050 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6171468 0.93 MAOA (0.53) MAOAMAOBPRKCIMAPK1NPSR1
SCHEMBL24362315 0.89 MAOA (0.49) MAOAMAOBPRKCIMAPK1NPSR1
SCHEMBL10102257 0.89 PBRM1 (0.50) MAOAMAOBPRKCIMAPK1NPSR1
SCHEMBL1275258 0.84 MEN1 (0.55) MAOAMAOBPRKCIMAPK1NPSR1
SCHEMBL423181 0.84 MAOA (0.60) MAOAMAOBPRKCIMAPK1NPSR1
SCHEMBL1032102 0.81 PBRM1 (0.50) MAOAMAOBPRKCIMAPK1NPSR1
SCHEMBL10389435 0.80 MEN1 (0.50) MAOAMAOBPRKCIMAPK1NPSR1
SCHEMBL10389430 0.80 MEN1 (0.50) MAOAMAOBPRKCIMAPK1NPSR1
SCHEMBL9620738 0.80 MAOA (0.55) MAOAMAOBPRKCIMAPK1NPSR1
SCHEMBL30811403 0.78 MAOA (0.53) MAOAMAOBPRKCIMAPK1NPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8536157-B2 Non-steroidal compounds THE UNIVERSITY OF MELBOURNE (AU) 2013-09-17 US disclosed
US-20120046255-A1 NON-STEROIDAL COMPOUNDS THE UNIVERSITY OF MELBOURNE of ROYAL PARADE PARKVILLE (AU) 2012-02-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120046255-A1 NON-STEROIDAL COMPOUNDS PTGES2, PTGES, PTGES3 MAOA 2304/4885MAOB 2633/4885PRKCI 2485/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.